Oral administration form for peptide pharmaceutical substances, in particular insulin
US5614219A · kind A · utility
66Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 1994 |
| Grant date | Mar 25, 1997 |
| Priority date | — |
| Expiry date | Sep 13, 2014 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG03C2001/0471
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A peroral administration form for peptidic medicaments contains the peptidic medicament, in particular insulin, distributed in a gelatine or gelatine derivate matrix, besides usual pharmaceutical excipients and additives. By selecting an appropriate gelatine, the medicament is released in the small or large intestine, so that it is no longer enzymatically decomposed by peptidases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.